Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4228788 | European Journal of Radiology | 2006 | 8 Pages |
Abstract
Accurate nodal staging is important in the management of any primary malignancy. The presence of nodal metastases has both therapeutic and prognostic implications. Lymphotropic nanoparticles are a new class of MRI contrast agents, which are promising in detecting minimal metastatic nodal disease particularly in normal sized lymph nodes. This paper discusses the technique and interpretation of lymphotropic nanoparticle enhanced MRI (LNMRI) and reviews the various trials evaluating nodal staging with ferumoxtran-10 enhanced MRI.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Mansi A. Saksena, Anuradha Saokar, Mukesh G. Harisinghani,